...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free
Message: Re: Standard of Care in BETonMACE
6
Mar 19, 2019 08:45AM

BDAZ would you know off hand then how similar the SoC for BETOnMACE would be to the SoC for EXAMINE?  Given the low usage of SGLT2 inhibitors and GLP1-R agonists in BoM one might think the SoC for both trials is at least similar?  If so perhaps one could expect similar placebo event rates?

2
Mar 19, 2019 10:44AM
5
Mar 19, 2019 11:28AM
Share
New Message
Please login to post a reply